Viral and Therapeutic Control of IFN-beta Promoter Stimulator 1 During Hepatitis C Virus Infection

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.0601523103
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Hepatitis C Virus and HIV Type 1 Co-Infection

Infectious Disease Reports
Infectious Diseases
2013English

HIV/AIDS and Viral Hepatitis B/C Co-Infection During Pregnancy

BMC Infectious Diseases
Infectious Diseases
2013English

Constraints on Viral Evolution During Chronic Hepatitis C Virus Infection Arising From a Common-Source Exposure

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2012English

Acute Hepatitis C Virus Infection

Eurosurveillance
EnvironmentalVirologyPublic HealthEpidemiologyMedicineOccupational Health
2008English

Diagnostic and Therapeutic Implications in a Case of Mixed Hepatitis C Virus (HCV) Infection

Hepatitis Monthly
HepatologyInfectious Diseases
2017English

Landscape of Post-Transcriptional Gene Regulation During Hepatitis C Virus Infection

Current Opinion in Virology
Virology
2015English

Dysregulation of Innate Immunity in Hepatitis C Virus Genotype 1 IL28B-unfavorable Genotype Patients: Impaired Viral Kinetics and Therapeutic Response

Hepatology
MedicineHepatology
2012English

Dynamics of HCV RNA Levels During Acute Hepatitis C Virus Infection

Journal of Medical Virology
VirologyInfectious Diseases
2014English

HLA-DRB1 in IFN Therapeutic Effect for Hepatitis C Patients.

Acta Hepatologica Japonica
Hepatology
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy